Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
The compound semaglutide mimics the bodys own GLP-1 hormone, proving itself a powerful tool in treating Type 2 Diabetes (UCLA Health)
GLP-1 receptor activation enhances insulin secretion, suppresses appetite, and slows gastric emptying
These include the time of day (e.g., a person will likely be more reactive to food cues at a time he/she usually eats), the environment, physical activity, sleep (lack of sleep tends to make one more prone to eat), stress, Anhedonia , emotional state, or appetite-regulating hormones (e.g., level of leptin, ghrelin and other hormones in circulation in the body)
Within the GLP-1 cohort, 76.4% were prescribed semaglutide, 18.1% dulaglutide, 5.1% liraglutide, 0.3% lixisenatide and 0.1% exenatide
US$ 20.61
US$ 28.59
US$ 26.68
US$ 29.62
US$ 29.46
US$ 24.11
US$ 21.77
US$ 24.06
